Adaptive Radiotherapy for an Uncommon Chloroma
Related Experiment Video
Updated: Mar 10, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Soufya Majdoul1, Laurianne Colson-Durand1, Nu Hanh To1
1Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), Créteil, France.
Abstract:
Granulocytic sarcomas, also referred to as chloromas or myeloid sarcomas, are extramedullary neoplasms that are composed of immature myeloid cells. This uncommon disease is known to be radiosensitive. However, the total dose and dose per fraction are not standardized. In addition, during the course of radiation therapy, significant reduction of the tumor is usually obtained. Thus, target volume reduction may require an intermediate radiotherapy plan evaluation for an adaptive treatment. A second plan at mid-dose is highly recommended.

